THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is 88339KAA0. A total of 23 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,232,000 | -57.0% | 1,339,000 | -55.9% | 0.00% | – |
Q2 2021 | $2,865,000 | -7.3% | 3,039,000 | 0.0% | 0.00% | – |
Q1 2021 | $3,092,000 | -27.3% | 3,039,000 | -33.0% | 0.00% | -100.0% |
Q4 2020 | $4,252,000 | +59.6% | 4,539,000 | +51.9% | 0.00% | 0.0% |
Q3 2020 | $2,664,000 | -14.6% | 2,989,000 | -9.5% | 0.00% | 0.0% |
Q2 2020 | $3,118,000 | +29.4% | 3,304,000 | +40.4% | 0.00% | 0.0% |
Q1 2020 | $2,409,000 | -48.0% | 2,354,000 | -48.2% | 0.00% | 0.0% |
Q4 2019 | $4,630,000 | +61.3% | 4,544,000 | +46.9% | 0.00% | 0.0% |
Q3 2019 | $2,871,000 | -28.7% | 3,094,000 | -33.4% | 0.00% | 0.0% |
Q2 2019 | $4,028,000 | -19.5% | 4,644,000 | -9.7% | 0.00% | 0.0% |
Q1 2019 | $5,003,000 | +22.3% | 5,144,000 | +28.6% | 0.00% | 0.0% |
Q4 2018 | $4,092,000 | -37.4% | 4,000,000 | -27.6% | 0.00% | -50.0% |
Q3 2018 | $6,536,000 | +4.1% | 5,528,000 | -12.9% | 0.00% | 0.0% |
Q2 2018 | $6,280,000 | +3024.4% | 6,348,000 | +3074.0% | 0.00% | – |
Q1 2018 | $201,000 | -8.2% | 200,000 | 0.0% | 0.00% | – |
Q4 2017 | $219,000 | -94.1% | 200,000 | -93.3% | 0.00% | -100.0% |
Q3 2017 | $3,683,000 | -9.0% | 3,000,000 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $4,049,000 | – | 3,000,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Context Capital Management, LLC | 25,388 | $23,544,000 | 2.40% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 49,675,000 | $46,013,000 | 1.22% |
DeepCurrents Investment Group LLC | 33,824,000 | $31,165,000 | 0.93% |
Aequim Alternative Investments LP | 13,920,000 | $12,909,000 | 0.50% |
Maven Securities LTD | 14,280,000 | $14,280,000 | 0.46% |
Saltoro Capital, LP | 1,350,000 | $1,252,000 | 0.44% |
Baupost Group | 30,000,000 | $27,640,000 | 0.25% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 5,500,000 | $5,182,000 | 0.12% |
ZAZOVE ASSOCIATES LLC | 1,250,000 | $1,163,000 | 0.10% |
HBK INVESTMENTS L P | 22,500,000 | $20,832,000 | 0.08% |